nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—CYP11B2—Hydrocortisone—rheumatoid arthritis	0.313	0.351	CbGbCtD
Metyrapone—CYP11B1—Hydrocortisone—rheumatoid arthritis	0.203	0.228	CbGbCtD
Metyrapone—ABCC3—Cyclosporine—rheumatoid arthritis	0.107	0.12	CbGbCtD
Metyrapone—ABCC3—Methotrexate—rheumatoid arthritis	0.0565	0.0633	CbGbCtD
Metyrapone—CYP2A6—Prednisolone—rheumatoid arthritis	0.0529	0.0593	CbGbCtD
Metyrapone—CYP2A6—Dexamethasone—rheumatoid arthritis	0.0312	0.035	CbGbCtD
Metyrapone—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0224	0.0251	CbGbCtD
Metyrapone—CYP2E1—Dexamethasone—rheumatoid arthritis	0.0206	0.0231	CbGbCtD
Metyrapone—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0165	0.0185	CbGbCtD
Metyrapone—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0125	0.014	CbGbCtD
Metyrapone—CYP3A4—Betamethasone—rheumatoid arthritis	0.0107	0.012	CbGbCtD
Metyrapone—CYP3A4—Prednisolone—rheumatoid arthritis	0.0106	0.0119	CbGbCtD
Metyrapone—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.01	0.0112	CbGbCtD
Metyrapone—CYP3A4—Prednisone—rheumatoid arthritis	0.00999	0.0112	CbGbCtD
Metyrapone—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00947	0.0106	CbGbCtD
Metyrapone—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00624	0.00699	CbGbCtD
Metyrapone—Bone marrow depression—Penicillamine—rheumatoid arthritis	0.00446	0.0474	CcSEcCtD
Metyrapone—Adrenal insufficiency—Prednisone—rheumatoid arthritis	0.00361	0.0383	CcSEcCtD
Metyrapone—Bone marrow depression—Azathioprine—rheumatoid arthritis	0.00232	0.0247	CcSEcCtD
Metyrapone—Hirsutism—Cyclosporine—rheumatoid arthritis	0.00197	0.0209	CcSEcCtD
Metyrapone—Pancytopenia—Auranofin—rheumatoid arthritis	0.00194	0.0206	CcSEcCtD
Metyrapone—Pancytopenia—Penicillamine—rheumatoid arthritis	0.00179	0.0191	CcSEcCtD
Metyrapone—Hirsutism—Prednisolone—rheumatoid arthritis	0.00179	0.019	CcSEcCtD
Metyrapone—Endocrine disorder—Leflunomide—rheumatoid arthritis	0.00179	0.019	CcSEcCtD
Metyrapone—Hirsutism—Hydrocortisone—rheumatoid arthritis	0.00175	0.0186	CcSEcCtD
Metyrapone—Hirsutism—Triamcinolone—rheumatoid arthritis	0.00165	0.0175	CcSEcCtD
Metyrapone—Hirsutism—Methylprednisolone—rheumatoid arthritis	0.00164	0.0174	CcSEcCtD
Metyrapone—Hypertension—Ergocalciferol—rheumatoid arthritis	0.00151	0.016	CcSEcCtD
Metyrapone—Hirsutism—Dexamethasone—rheumatoid arthritis	0.00149	0.0159	CcSEcCtD
Metyrapone—Hirsutism—Betamethasone—rheumatoid arthritis	0.00149	0.0159	CcSEcCtD
Metyrapone—Alopecia—Auranofin—rheumatoid arthritis	0.00145	0.0154	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisolone—rheumatoid arthritis	0.0014	0.0149	CcSEcCtD
Metyrapone—Angiopathy—Penicillamine—rheumatoid arthritis	0.00137	0.0146	CcSEcCtD
Metyrapone—Alopecia—Penicillamine—rheumatoid arthritis	0.00134	0.0142	CcSEcCtD
Metyrapone—Hirsutism—Prednisone—rheumatoid arthritis	0.0013	0.0138	CcSEcCtD
Metyrapone—Dermatitis atopic—Triamcinolone—rheumatoid arthritis	0.00129	0.0137	CcSEcCtD
Metyrapone—Endocrine disorder—Hydrocortisone—rheumatoid arthritis	0.00123	0.013	CcSEcCtD
Metyrapone—Pain—Ergocalciferol—rheumatoid arthritis	0.00122	0.013	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Penicillamine—rheumatoid arthritis	0.00111	0.0118	CcSEcCtD
Metyrapone—Skin disorder—Penicillamine—rheumatoid arthritis	0.00104	0.0111	CcSEcCtD
Metyrapone—Dermatitis atopic—Prednisone—rheumatoid arthritis	0.00102	0.0108	CcSEcCtD
Metyrapone—Gastrointestinal pain—Auranofin—rheumatoid arthritis	0.000951	0.0101	CcSEcCtD
Metyrapone—Abdominal discomfort—Azathioprine—rheumatoid arthritis	0.000943	0.01	CcSEcCtD
Metyrapone—Bone marrow depression—Methotrexate—rheumatoid arthritis	0.000935	0.00994	CcSEcCtD
Metyrapone—Pancytopenia—Azathioprine—rheumatoid arthritis	0.000934	0.00993	CcSEcCtD
Metyrapone—Abdominal pain—Auranofin—rheumatoid arthritis	0.00092	0.00977	CcSEcCtD
Metyrapone—Endocrine disorder—Prednisone—rheumatoid arthritis	0.000912	0.00969	CcSEcCtD
Metyrapone—Pancytopenia—Leflunomide—rheumatoid arthritis	0.000882	0.00937	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—GC—rheumatoid arthritis	0.000852	0.0642	CbGpPWpGaD
Metyrapone—Nausea—Ergocalciferol—rheumatoid arthritis	0.000848	0.00901	CcSEcCtD
Metyrapone—Vomiting—Auranofin—rheumatoid arthritis	0.00074	0.00786	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—GC—rheumatoid arthritis	0.000734	0.0553	CbGpPWpGaD
Metyrapone—Alopecia—Azathioprine—rheumatoid arthritis	0.000696	0.00739	CcSEcCtD
Metyrapone—Nausea—Auranofin—rheumatoid arthritis	0.000691	0.00734	CcSEcCtD
Metyrapone—Abdominal discomfort—Cyclosporine—rheumatoid arthritis	0.000687	0.0073	CcSEcCtD
Metyrapone—Vomiting—Penicillamine—rheumatoid arthritis	0.000683	0.00726	CcSEcCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—BDKRB2—rheumatoid arthritis	0.000665	0.0501	CbGpPWpGaD
Metyrapone—Alopecia—Leflunomide—rheumatoid arthritis	0.000657	0.00698	CcSEcCtD
Metyrapone—CYP11B2—Glucocorticoid biosynthesis—POMC—rheumatoid arthritis	0.000651	0.0491	CbGpPWpGaD
Metyrapone—Nausea—Penicillamine—rheumatoid arthritis	0.000638	0.00678	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.00058	0.00616	CcSEcCtD
Metyrapone—CYP11B1—Glucocorticoid biosynthesis—POMC—rheumatoid arthritis	0.000561	0.0423	CbGpPWpGaD
Metyrapone—Hypertension—Leflunomide—rheumatoid arthritis	0.000559	0.00594	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000547	0.00582	CcSEcCtD
Metyrapone—Skin disorder—Azathioprine—rheumatoid arthritis	0.000543	0.00577	CcSEcCtD
Metyrapone—Hypotension—Azathioprine—rheumatoid arthritis	0.000523	0.00555	CcSEcCtD
Metyrapone—Angiopathy—Cyclosporine—rheumatoid arthritis	0.000521	0.00553	CcSEcCtD
Metyrapone—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000518	0.0055	CcSEcCtD
Metyrapone—Skin disorder—Leflunomide—rheumatoid arthritis	0.000513	0.00545	CcSEcCtD
Metyrapone—Alopecia—Cyclosporine—rheumatoid arthritis	0.000507	0.00539	CcSEcCtD
Metyrapone—Hypotension—Leflunomide—rheumatoid arthritis	0.000494	0.00525	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000483	0.00513	CcSEcCtD
Metyrapone—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000457	0.00486	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000456	0.00485	CcSEcCtD
Metyrapone—Pain—Leflunomide—rheumatoid arthritis	0.000452	0.0048	CcSEcCtD
Metyrapone—Abdominal pain—Azathioprine—rheumatoid arthritis	0.000442	0.0047	CcSEcCtD
Metyrapone—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000435	0.00462	CcSEcCtD
Metyrapone—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000432	0.00459	CcSEcCtD
Metyrapone—Hypertension—Cyclosporine—rheumatoid arthritis	0.000431	0.00458	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000422	0.00449	CcSEcCtD
Metyrapone—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000418	0.00444	CcSEcCtD
Metyrapone—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.0004	0.00425	CcSEcCtD
Metyrapone—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000396	0.00421	CcSEcCtD
Metyrapone—Angiopathy—Betamethasone—rheumatoid arthritis	0.000395	0.0042	CcSEcCtD
Metyrapone—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000395	0.0042	CcSEcCtD
Metyrapone—Hypertension—Prednisolone—rheumatoid arthritis	0.000392	0.00417	CcSEcCtD
Metyrapone—Alopecia—Dexamethasone—rheumatoid arthritis	0.000385	0.00409	CcSEcCtD
Metyrapone—Alopecia—Betamethasone—rheumatoid arthritis	0.000385	0.00409	CcSEcCtD
Metyrapone—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000383	0.00407	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—GRK6—rheumatoid arthritis	0.00038	0.0287	CbGpPWpGaD
Metyrapone—Abdominal discomfort—Methotrexate—rheumatoid arthritis	0.00038	0.00404	CcSEcCtD
Metyrapone—Pancytopenia—Methotrexate—rheumatoid arthritis	0.000376	0.004	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000375	0.00399	CcSEcCtD
Metyrapone—Dizziness—Azathioprine—rheumatoid arthritis	0.00037	0.00393	CcSEcCtD
Metyrapone—Hypertension—Triamcinolone—rheumatoid arthritis	0.000361	0.00384	CcSEcCtD
Metyrapone—Hypertension—Methylprednisolone—rheumatoid arthritis	0.00036	0.00383	CcSEcCtD
Metyrapone—Vomiting—Azathioprine—rheumatoid arthritis	0.000356	0.00378	CcSEcCtD
Metyrapone—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000355	0.00378	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000353	0.00375	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000352	0.00374	CcSEcCtD
Metyrapone—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000352	0.00374	CcSEcCtD
Metyrapone—Headache—Azathioprine—rheumatoid arthritis	0.00035	0.00372	CcSEcCtD
Metyrapone—Dizziness—Leflunomide—rheumatoid arthritis	0.000349	0.00371	CcSEcCtD
Metyrapone—Pain—Cyclosporine—rheumatoid arthritis	0.000349	0.0037	CcSEcCtD
Metyrapone—Angiopathy—Prednisone—rheumatoid arthritis	0.000344	0.00366	CcSEcCtD
Metyrapone—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000339	0.0036	CcSEcCtD
Metyrapone—Vomiting—Leflunomide—rheumatoid arthritis	0.000336	0.00357	CcSEcCtD
Metyrapone—Alopecia—Prednisone—rheumatoid arthritis	0.000335	0.00356	CcSEcCtD
Metyrapone—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000334	0.00355	CcSEcCtD
Metyrapone—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000333	0.00354	CcSEcCtD
Metyrapone—Nausea—Azathioprine—rheumatoid arthritis	0.000332	0.00353	CcSEcCtD
Metyrapone—Headache—Leflunomide—rheumatoid arthritis	0.000331	0.00352	CcSEcCtD
Metyrapone—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000331	0.00351	CcSEcCtD
Metyrapone—Hypertension—Dexamethasone—rheumatoid arthritis	0.000327	0.00348	CcSEcCtD
Metyrapone—Hypertension—Betamethasone—rheumatoid arthritis	0.000327	0.00348	CcSEcCtD
Metyrapone—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000322	0.00342	CcSEcCtD
Metyrapone—ABCC3—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	0.000321	0.0242	CbGpPWpGaD
Metyrapone—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—rheumatoid arthritis	0.00032	0.0241	CbGpPWpGaD
Metyrapone—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000318	0.00338	CcSEcCtD
Metyrapone—Pain—Prednisolone—rheumatoid arthritis	0.000317	0.00337	CcSEcCtD
Metyrapone—Nausea—Leflunomide—rheumatoid arthritis	0.000314	0.00333	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000313	0.00332	CcSEcCtD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—NOS3—rheumatoid arthritis	0.000311	0.0234	CbGpPWpGaD
Metyrapone—Pain—Hydrocortisone—rheumatoid arthritis	0.00031	0.00329	CcSEcCtD
Metyrapone—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000304	0.00323	CcSEcCtD
Metyrapone—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000304	0.00323	CcSEcCtD
Metyrapone—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000296	0.00315	CcSEcCtD
Metyrapone—Pain—Triamcinolone—rheumatoid arthritis	0.000292	0.0031	CcSEcCtD
Metyrapone—Hypotension—Dexamethasone—rheumatoid arthritis	0.000289	0.00307	CcSEcCtD
Metyrapone—Hypotension—Betamethasone—rheumatoid arthritis	0.000289	0.00307	CcSEcCtD
Metyrapone—Angiopathy—Methotrexate—rheumatoid arthritis	0.000288	0.00306	CcSEcCtD
Metyrapone—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000286	0.00304	CcSEcCtD
Metyrapone—Hypertension—Prednisone—rheumatoid arthritis	0.000285	0.00303	CcSEcCtD
Metyrapone—Alopecia—Methotrexate—rheumatoid arthritis	0.00028	0.00298	CcSEcCtD
Metyrapone—CYP11B2—Endogenous sterols—POMC—rheumatoid arthritis	0.00028	0.0211	CbGpPWpGaD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000279	0.00297	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000278	0.00296	CcSEcCtD
Metyrapone—Dizziness—Cyclosporine—rheumatoid arthritis	0.00027	0.00286	CcSEcCtD
Metyrapone—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000269	0.00286	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000267	0.00284	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000267	0.00284	CcSEcCtD
Metyrapone—Pain—Dexamethasone—rheumatoid arthritis	0.000265	0.00281	CcSEcCtD
Metyrapone—Pain—Betamethasone—rheumatoid arthritis	0.000265	0.00281	CcSEcCtD
Metyrapone—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000264	0.00281	CcSEcCtD
Metyrapone—Skin disorder—Prednisone—rheumatoid arthritis	0.000262	0.00278	CcSEcCtD
Metyrapone—Vomiting—Cyclosporine—rheumatoid arthritis	0.000259	0.00275	CcSEcCtD
Metyrapone—Headache—Cyclosporine—rheumatoid arthritis	0.000255	0.00271	CcSEcCtD
Metyrapone—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000253	0.00269	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000253	0.00269	CcSEcCtD
Metyrapone—Dizziness—Prednisolone—rheumatoid arthritis	0.000245	0.00261	CcSEcCtD
Metyrapone—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000245	0.0026	CcSEcCtD
Metyrapone—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000245	0.0026	CcSEcCtD
Metyrapone—Nausea—Cyclosporine—rheumatoid arthritis	0.000242	0.00257	CcSEcCtD
Metyrapone—CYP11B1—Endogenous sterols—POMC—rheumatoid arthritis	0.000241	0.0182	CbGpPWpGaD
Metyrapone—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00024	0.00255	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000233	0.00248	CcSEcCtD
Metyrapone—Headache—Prednisolone—rheumatoid arthritis	0.000232	0.00247	CcSEcCtD
Metyrapone—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00023	0.00245	CcSEcCtD
Metyrapone—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—rheumatoid arthritis	0.000228	0.0172	CbGpPWpGaD
Metyrapone—Headache—Hydrocortisone—rheumatoid arthritis	0.000227	0.00241	CcSEcCtD
Metyrapone—Dizziness—Triamcinolone—rheumatoid arthritis	0.000226	0.0024	CcSEcCtD
Metyrapone—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000225	0.00239	CcSEcCtD
Metyrapone—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000221	0.00235	CcSEcCtD
Metyrapone—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.00022	0.00234	CcSEcCtD
Metyrapone—Nausea—Prednisolone—rheumatoid arthritis	0.00022	0.00234	CcSEcCtD
Metyrapone—Skin disorder—Methotrexate—rheumatoid arthritis	0.000219	0.00233	CcSEcCtD
Metyrapone—Vomiting—Triamcinolone—rheumatoid arthritis	0.000217	0.00231	CcSEcCtD
Metyrapone—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000216	0.0023	CcSEcCtD
Metyrapone—Nausea—Hydrocortisone—rheumatoid arthritis	0.000215	0.00229	CcSEcCtD
Metyrapone—Headache—Triamcinolone—rheumatoid arthritis	0.000214	0.00227	CcSEcCtD
Metyrapone—Headache—Methylprednisolone—rheumatoid arthritis	0.000213	0.00227	CcSEcCtD
Metyrapone—Abdominal pain—Prednisone—rheumatoid arthritis	0.000213	0.00226	CcSEcCtD
Metyrapone—ABCC3—Recycling of bile acids and salts—ALB—rheumatoid arthritis	0.000212	0.0159	CbGpPWpGaD
Metyrapone—Hypotension—Methotrexate—rheumatoid arthritis	0.000211	0.00224	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of steroid hormones and vitamin D—POMC—rheumatoid arthritis	0.00021	0.0158	CbGpPWpGaD
Metyrapone—CYP11B2—ACE Inhibitor Pathway—TGFB1—rheumatoid arthritis	0.000205	0.0155	CbGpPWpGaD
Metyrapone—Dizziness—Dexamethasone—rheumatoid arthritis	0.000205	0.00218	CcSEcCtD
Metyrapone—Dizziness—Betamethasone—rheumatoid arthritis	0.000205	0.00218	CcSEcCtD
Metyrapone—Nausea—Triamcinolone—rheumatoid arthritis	0.000203	0.00215	CcSEcCtD
Metyrapone—Nausea—Methylprednisolone—rheumatoid arthritis	0.000202	0.00215	CcSEcCtD
Metyrapone—Vomiting—Dexamethasone—rheumatoid arthritis	0.000197	0.00209	CcSEcCtD
Metyrapone—Vomiting—Betamethasone—rheumatoid arthritis	0.000197	0.00209	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000195	0.00207	CcSEcCtD
Metyrapone—Headache—Dexamethasone—rheumatoid arthritis	0.000194	0.00206	CcSEcCtD
Metyrapone—Headache—Betamethasone—rheumatoid arthritis	0.000194	0.00206	CcSEcCtD
Metyrapone—Pain—Methotrexate—rheumatoid arthritis	0.000193	0.00205	CcSEcCtD
Metyrapone—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000185	0.0139	CbGpPWpGaD
Metyrapone—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000184	0.00196	CcSEcCtD
Metyrapone—Nausea—Dexamethasone—rheumatoid arthritis	0.000184	0.00195	CcSEcCtD
Metyrapone—Nausea—Betamethasone—rheumatoid arthritis	0.000184	0.00195	CcSEcCtD
Metyrapone—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—rheumatoid arthritis	0.000181	0.0136	CbGpPWpGaD
Metyrapone—Dizziness—Prednisone—rheumatoid arthritis	0.000178	0.00189	CcSEcCtD
Metyrapone—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000178	0.00189	CcSEcCtD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—rheumatoid arthritis	0.000175	0.0132	CbGpPWpGaD
Metyrapone—Vomiting—Prednisone—rheumatoid arthritis	0.000171	0.00182	CcSEcCtD
Metyrapone—Headache—Prednisone—rheumatoid arthritis	0.000169	0.00179	CcSEcCtD
Metyrapone—ABCC3—Fluoropyrimidine Activity—MTHFR—rheumatoid arthritis	0.000163	0.0123	CbGpPWpGaD
Metyrapone—Nausea—Prednisone—rheumatoid arthritis	0.00016	0.0017	CcSEcCtD
Metyrapone—Dizziness—Methotrexate—rheumatoid arthritis	0.000149	0.00158	CcSEcCtD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000148	0.0112	CbGpPWpGaD
Metyrapone—Vomiting—Methotrexate—rheumatoid arthritis	0.000143	0.00152	CcSEcCtD
Metyrapone—Headache—Methotrexate—rheumatoid arthritis	0.000141	0.0015	CcSEcCtD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—PRKCQ—rheumatoid arthritis	0.000135	0.0102	CbGpPWpGaD
Metyrapone—Nausea—Methotrexate—rheumatoid arthritis	0.000134	0.00142	CcSEcCtD
Metyrapone—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.00013	0.00979	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	0.000128	0.00962	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—rheumatoid arthritis	0.000116	0.00874	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—PTK2—rheumatoid arthritis	0.000115	0.00868	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—IL18—rheumatoid arthritis	0.000113	0.00851	CbGpPWpGaD
Metyrapone—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	0.000112	0.00844	CbGpPWpGaD
Metyrapone—ABCC3—Bile acid and bile salt metabolism—ALB—rheumatoid arthritis	0.000111	0.00833	CbGpPWpGaD
Metyrapone—CYP11B2—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	0.000105	0.00794	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—MTHFR—rheumatoid arthritis	0.000102	0.00768	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—rheumatoid arthritis	0.000101	0.00758	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	9.89e-05	0.00745	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	9.19e-05	0.00693	CbGpPWpGaD
Metyrapone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	9.14e-05	0.00689	CbGpPWpGaD
Metyrapone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—rheumatoid arthritis	9.13e-05	0.00688	CbGpPWpGaD
Metyrapone—CYP11B1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	9.07e-05	0.00684	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—TLR4—rheumatoid arthritis	9.07e-05	0.00683	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	8.73e-05	0.00658	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	8.73e-05	0.00658	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	8.52e-05	0.00642	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.12e-05	0.00612	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—POMC—rheumatoid arthritis	7.95e-05	0.00599	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	7.52e-05	0.00567	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	7.52e-05	0.00567	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	7.43e-05	0.0056	CbGpPWpGaD
Metyrapone—CYP2E1—Tryptophan metabolism—CAT—rheumatoid arthritis	7.39e-05	0.00557	CbGpPWpGaD
Metyrapone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	7.38e-05	0.00556	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.12e-05	0.00536	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	7e-05	0.00527	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—NOS3—rheumatoid arthritis	6.93e-05	0.00523	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—FADS2—rheumatoid arthritis	6.6e-05	0.00497	CbGpPWpGaD
Metyrapone—ABCC3—Fluoropyrimidine Activity—TP53—rheumatoid arthritis	6.17e-05	0.00465	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—CXCL8—rheumatoid arthritis	6.15e-05	0.00464	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	6.13e-05	0.00462	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	6.13e-05	0.00462	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—IL2—rheumatoid arthritis	5.88e-05	0.00443	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—FADS2—rheumatoid arthritis	5.69e-05	0.00429	CbGpPWpGaD
Metyrapone—CYP11B2—Biological oxidations—POMC—rheumatoid arthritis	5.59e-05	0.00422	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—NFKB1—rheumatoid arthritis	5.5e-05	0.00415	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.48e-05	0.00413	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	5.42e-05	0.00408	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	5.42e-05	0.00408	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—MAPK8—rheumatoid arthritis	5.41e-05	0.00408	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—AGER—rheumatoid arthritis	5.4e-05	0.00407	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	5.15e-05	0.00388	CbGpPWpGaD
Metyrapone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	5.05e-05	0.0038	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	5.04e-05	0.0038	CbGpPWpGaD
Metyrapone—CYP11B1—Biological oxidations—POMC—rheumatoid arthritis	4.82e-05	0.00363	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	4.73e-05	0.00356	CbGpPWpGaD
Metyrapone—CYP11B1—Corticotropin-releasing hormone—TGFB1—rheumatoid arthritis	4.58e-05	0.00346	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	4.42e-05	0.00333	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PLD4—rheumatoid arthritis	4.4e-05	0.00332	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ACAN—rheumatoid arthritis	4.25e-05	0.0032	CbGpPWpGaD
Metyrapone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	4.24e-05	0.0032	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	4.2e-05	0.00317	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—FADS2—rheumatoid arthritis	4.09e-05	0.00309	CbGpPWpGaD
Metyrapone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	4.09e-05	0.00308	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—SLC25A12—rheumatoid arthritis	4e-05	0.00301	CbGpPWpGaD
Metyrapone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	3.99e-05	0.00301	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—GC—rheumatoid arthritis	3.89e-05	0.00293	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGES—rheumatoid arthritis	3.89e-05	0.00293	CbGpPWpGaD
Metyrapone—CYP2A6—Fluoropyrimidine Activity—TP53—rheumatoid arthritis	3.87e-05	0.00291	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PLD4—rheumatoid arthritis	3.79e-05	0.00286	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ACAN—rheumatoid arthritis	3.66e-05	0.00276	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PLB1—rheumatoid arthritis	3.62e-05	0.00272	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—SLC25A12—rheumatoid arthritis	3.45e-05	0.0026	CbGpPWpGaD
Metyrapone—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	3.43e-05	0.00258	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.4e-05	0.00256	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—AGER—rheumatoid arthritis	3.38e-05	0.00255	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—GC—rheumatoid arthritis	3.35e-05	0.00253	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGES—rheumatoid arthritis	3.35e-05	0.00253	CbGpPWpGaD
Metyrapone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	3.23e-05	0.00244	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	3.21e-05	0.00242	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MED1—rheumatoid arthritis	3.17e-05	0.00239	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PLB1—rheumatoid arthritis	3.12e-05	0.00235	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—B3GNT2—rheumatoid arthritis	2.95e-05	0.00222	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ACP5—rheumatoid arthritis	2.95e-05	0.00222	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MED1—rheumatoid arthritis	2.73e-05	0.00206	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PLD4—rheumatoid arthritis	2.73e-05	0.00206	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—BGN—rheumatoid arthritis	2.65e-05	0.002	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ACAN—rheumatoid arthritis	2.64e-05	0.00199	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—FADS2—rheumatoid arthritis	2.56e-05	0.00193	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ACP5—rheumatoid arthritis	2.54e-05	0.00191	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—B3GNT2—rheumatoid arthritis	2.54e-05	0.00191	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—SLC25A12—rheumatoid arthritis	2.48e-05	0.00187	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALOX5—rheumatoid arthritis	2.44e-05	0.00184	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGES—rheumatoid arthritis	2.41e-05	0.00182	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GC—rheumatoid arthritis	2.41e-05	0.00182	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—BGN—rheumatoid arthritis	2.29e-05	0.00172	CbGpPWpGaD
Metyrapone—ABCC3—NRF2 pathway—TGFB1—rheumatoid arthritis	2.28e-05	0.00172	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PLB1—rheumatoid arthritis	2.24e-05	0.00169	CbGpPWpGaD
Metyrapone—CYP2A6—Biological oxidations—POMC—rheumatoid arthritis	2.17e-05	0.00164	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.15e-05	0.00162	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALOX5—rheumatoid arthritis	2.1e-05	0.00159	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—FADS2—rheumatoid arthritis	2.03e-05	0.00153	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ENO1—rheumatoid arthritis	1.99e-05	0.0015	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MED1—rheumatoid arthritis	1.97e-05	0.00148	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.96e-05	0.00148	CbGpPWpGaD
Metyrapone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.85e-05	0.0014	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.85e-05	0.00139	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—B3GNT2—rheumatoid arthritis	1.83e-05	0.00138	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ACP5—rheumatoid arthritis	1.83e-05	0.00138	CbGpPWpGaD
Metyrapone—CYP2E1—Biological oxidations—POMC—rheumatoid arthritis	1.72e-05	0.00129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ENO1—rheumatoid arthritis	1.72e-05	0.00129	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.71e-05	0.00129	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLD4—rheumatoid arthritis	1.71e-05	0.00129	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.69e-05	0.00127	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ACAN—rheumatoid arthritis	1.65e-05	0.00125	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—BGN—rheumatoid arthritis	1.65e-05	0.00124	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC25A12—rheumatoid arthritis	1.55e-05	0.00117	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALOX5—rheumatoid arthritis	1.52e-05	0.00114	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GC—rheumatoid arthritis	1.51e-05	0.00114	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGES—rheumatoid arthritis	1.51e-05	0.00114	CbGpPWpGaD
Metyrapone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.5e-05	0.00113	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.48e-05	0.00111	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—CAT—rheumatoid arthritis	1.43e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP2A6—NRF2 pathway—TGFB1—rheumatoid arthritis	1.43e-05	0.00108	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLB1—rheumatoid arthritis	1.41e-05	0.00106	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLD4—rheumatoid arthritis	1.35e-05	0.00102	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.33e-05	0.001	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ACAN—rheumatoid arthritis	1.31e-05	0.000984	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ENO1—rheumatoid arthritis	1.24e-05	0.000931	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—CAT—rheumatoid arthritis	1.23e-05	0.000931	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MED1—rheumatoid arthritis	1.23e-05	0.000929	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC25A12—rheumatoid arthritis	1.23e-05	0.000926	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.22e-05	0.000916	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—MTHFR—rheumatoid arthritis	1.2e-05	0.000901	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GC—rheumatoid arthritis	1.19e-05	0.0009	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGES—rheumatoid arthritis	1.19e-05	0.0009	CbGpPWpGaD
Metyrapone—ABCC3—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	1.16e-05	0.000871	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ACP5—rheumatoid arthritis	1.15e-05	0.000863	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—B3GNT2—rheumatoid arthritis	1.15e-05	0.000863	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLB1—rheumatoid arthritis	1.11e-05	0.000837	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.06e-05	0.000801	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—BGN—rheumatoid arthritis	1.03e-05	0.000777	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—MTHFR—rheumatoid arthritis	1.03e-05	0.000777	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MED1—rheumatoid arthritis	9.74e-06	0.000734	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POMC—rheumatoid arthritis	9.56e-06	0.000721	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALOX5—rheumatoid arthritis	9.49e-06	0.000715	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	9.4e-06	0.000709	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—B3GNT2—rheumatoid arthritis	9.05e-06	0.000682	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ACP5—rheumatoid arthritis	9.05e-06	0.000682	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAT—rheumatoid arthritis	8.89e-06	0.00067	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—rheumatoid arthritis	8.72e-06	0.000657	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NOS3—rheumatoid arthritis	8.34e-06	0.000629	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POMC—rheumatoid arthritis	8.24e-06	0.000621	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—BGN—rheumatoid arthritis	8.15e-06	0.000614	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	7.97e-06	0.000601	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ENO1—rheumatoid arthritis	7.74e-06	0.000583	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—rheumatoid arthritis	7.63e-06	0.000575	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—rheumatoid arthritis	7.51e-06	0.000566	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALOX5—rheumatoid arthritis	7.5e-06	0.000565	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—rheumatoid arthritis	7.42e-06	0.000559	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NOS3—rheumatoid arthritis	7.19e-06	0.000542	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—rheumatoid arthritis	6.57e-06	0.000495	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	6.27e-06	0.000473	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ENO1—rheumatoid arthritis	6.12e-06	0.000461	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	6.06e-06	0.000457	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POMC—rheumatoid arthritis	5.94e-06	0.000447	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	5.7e-06	0.000429	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAT—rheumatoid arthritis	5.57e-06	0.00042	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GC—rheumatoid arthritis	5.54e-06	0.000418	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	5.54e-06	0.000418	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—rheumatoid arthritis	5.41e-06	0.000408	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NOS3—rheumatoid arthritis	5.18e-06	0.00039	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	5.15e-06	0.000388	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—rheumatoid arthritis	4.73e-06	0.000357	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—rheumatoid arthritis	4.65e-06	0.00035	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MED1—rheumatoid arthritis	4.52e-06	0.000341	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAT—rheumatoid arthritis	4.4e-06	0.000332	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.2e-06	0.000317	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.2e-06	0.000317	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—BGN—rheumatoid arthritis	3.78e-06	0.000285	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POMC—rheumatoid arthritis	3.72e-06	0.00028	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—rheumatoid arthritis	3.67e-06	0.000277	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.48e-06	0.000262	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—rheumatoid arthritis	3.39e-06	0.000255	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NOS3—rheumatoid arthritis	3.24e-06	0.000244	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—rheumatoid arthritis	2.97e-06	0.000223	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POMC—rheumatoid arthritis	2.94e-06	0.000221	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	2.84e-06	0.000214	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—rheumatoid arthritis	2.68e-06	0.000202	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NOS3—rheumatoid arthritis	2.56e-06	0.000193	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—rheumatoid arthritis	2.34e-06	0.000177	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.04e-06	0.000154	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.7e-06	0.000128	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.36e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.24e-06	9.37e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.19e-06	8.96e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.09e-06	8.19e-05	CbGpPWpGaD
